Neurosteroids modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes

Area of Science:

• Neuroscience
• Pharmacology
• Endocrinology

Background:

• Progesterone and its metabolites are known allosteric activators of GABA(A) receptors.
• The effects of these neurosteroids on brain nicotinic receptors remain less understood.
• Nicotinic acetylcholine receptors (nAChRs) play crucial roles in neurotransmission and cognitive functions.

Purpose of the Study:

• To investigate the modulatory effects of progesterone and its A-ring reduced metabolites on brain nicotinic receptors.
• To determine the mechanism of action (activation or inhibition) and receptor subtype specificity.
• To compare the sensitivity of different nicotinic receptor assays to neurosteroid effects.

Main Methods:

• Utilized an 86Rb+ efflux assay to assess alpha4beta2-type nicotinic receptor function.
• Employed [3H]dopamine release assays, potentially modulated by alpha3-containing nicotinic receptors.
• Measured steroid inhibition kinetics, including development and reversal of effects, and assessed impact on nicotine binding rates and equilibrium.

Main Results:

• Progesterone's A-ring reduced metabolites noncompetitively inhibited both 86Rb+ efflux and dopamine release assays.
• Progesterone itself selectively inhibited the 86Rb+ efflux assay.
• The 86Rb+ efflux assay demonstrated slightly higher sensitivity to neurosteroid inhibition compared to the dopamine release assay.
• Inhibition onset was rapid (t1/2 = 0.4 min), while reversal was slow (t1/2 = 10-15 min).
• Neurosteroid application did not affect nicotine binding kinetics or equilibrium.

Conclusions:

• Neurosteroids, including progesterone metabolites, function as allosteric inhibitors of brain nicotinic receptors.
• These findings suggest a novel inhibitory role for neurosteroids in regulating neuronal excitability and function via nAChRs.
• The differential effects and sensitivities highlight the complexity of neurosteroid-nAChR interactions.